Principal Financial Group Inc. Has $5.22 Million Position in Schrödinger, Inc. (NASDAQ:SDGR)

Principal Financial Group Inc. increased its position in shares of Schrödinger, Inc. (NASDAQ:SDGR) by 3.1% during the 4th quarter, HoldingsChannel.com reports. The fund owned 270,449 shares of the company’s stock after purchasing an additional 8,138 shares during the period. Principal Financial Group Inc.’s holdings in Schrödinger were worth $5,217,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the business. Private Advisor Group LLC boosted its stake in Schrödinger by 20.5% in the third quarter. Private Advisor Group LLC now owns 12,150 shares of the company’s stock valued at $225,000 after buying an additional 2,065 shares in the last quarter. Harbor Capital Advisors Inc. lifted its holdings in shares of Schrödinger by 5.0% in the third quarter. Harbor Capital Advisors Inc. now owns 13,059 shares of the company’s stock worth $242,000 after acquiring an additional 622 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its stake in shares of Schrödinger by 1.4% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,191,054 shares of the company’s stock valued at $40,644,000 after purchasing an additional 29,920 shares in the last quarter. Pier 88 Investment Partners LLC grew its holdings in shares of Schrödinger by 83.6% during the 3rd quarter. Pier 88 Investment Partners LLC now owns 77,130 shares of the company’s stock valued at $1,431,000 after purchasing an additional 35,120 shares during the last quarter. Finally, KBC Group NV grew its holdings in shares of Schrödinger by 45.4% during the 3rd quarter. KBC Group NV now owns 2,508 shares of the company’s stock valued at $47,000 after purchasing an additional 783 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Schrödinger Stock Performance

SDGR stock opened at $21.24 on Tuesday. The company has a market capitalization of $1.55 billion, a P/E ratio of -9.08 and a beta of 1.61. The company has a fifty day moving average price of $22.37 and a 200-day moving average price of $20.62. Schrödinger, Inc. has a 52-week low of $16.67 and a 52-week high of $29.15.

Schrödinger (NASDAQ:SDGR) last announced its earnings results on Wednesday, February 26th. The company reported ($0.55) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.20). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The company had revenue of $88.32 million for the quarter, compared to the consensus estimate of $83.20 million. As a group, sell-side analysts forecast that Schrödinger, Inc. will post -2.37 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on SDGR shares. KeyCorp increased their price objective on shares of Schrödinger from $25.00 to $27.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Piper Sandler dropped their price target on Schrödinger from $50.00 to $45.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th. Finally, BMO Capital Markets raised their price objective on Schrödinger from $25.00 to $28.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. One analyst has rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $32.29.

About Schrödinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.